{"shortageName": "Vitamin K (Phytonadione) Injection", "shortageStatus": "Resolved Shortages", "shortageRevisionDate": " Jul 05, 2018", "shortageAshpURL": "https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=100", "fileCreateDate": "Mon Aug 13 20:38:38 2018", "affectedProds": [], "shortageReasons": ["Pfizer had vitamin K injection on market reserve due to increased demand. The increased demand is thought to be due to increased use of synthetic inhaled cannabinoids laced with anticoagulants.", "Oral vitamin K is not affected by this shortage."], "availableProds": ["Vitamin K injection, Amphastar, 2 mg/mL, 0.5 mL SAF-T-JET prefilled syringe, 10 count, NDC 76329-1240-01", "Vitamin K injection, Pfizer, 10 mg/mL, 1 mL ampule, 25 count, NDC 00409-9158-01", "Vitamin K injection, Pfizer, 2 mg/mL, 0.5 mL ampule, 25 count, NDC 00409-9157-01"], "resupplyDates": ["Pfizer has vitamin K injection in 1 mg/mL 0.5 mL ampules and 10 mg/mL 1 mL ampules available."], "implications": [], "safety": ["Avoid off-label oral administration of injectable Vitamin K during the shortage.", "Vitamin K from Amphastar contains polysorbate 80 and propylene glycol.", "Vitamin K from Hospira contains benzyl alcohol. The product labeling states there is no evidence to suggest toxicity of benzyl alcohol if used as recommended."], "alternatives": [], "references": []}